2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of UNH based on the data you provided, broken down into sections and summarized at the end:

**1) Return Rate Comparison**

*   **Ticker:** UNH (UnitedHealth Group Inc)
*   **Company Overview:** A diversified health care company offering a wide range of products and services.
*   **UNH Cumulative Return:** -20.24%
*   **S&P 500 (VOO) Cumulative Return:** 91.00%
*   **Divergence:**
    *   **Current:** -113.3
    *   **Max:** 29.8
    *   **Min:** -124.6
    *   **Relative Divergence:** 7.3

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) over the period examined. The current divergence of -113.3 indicates a substantial gap in returns. A relative divergence of 7.3 suggests that the current divergence is near the bottom of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta | Cap(B) |
|------------|---------|-------|---------|------|--------|
| 2016-2018  | 22.0%   | 18.6% | 19.0%   | 0.9  | 225.7  |
| 2017-2019  | 27.0%   | 18.6% | 10.0%   | 0.9  | 266.3  |
| 2018-2020  | -41.0%  | 32.5% | -62.0%  | 1.1  | 317.7  |
| 2019-2021  | 16.0%   | 32.5% | -27.0%  | 1.1  | 454.9  |
| 2020-2022  | 0.0%    | 31.5% | 2.0%    | 0.9  | 480.3  |
| 2021-2023  | 23.0%   | 13.4% | 23.0%   | 0.5  | 476.9  |
| 2022-2024  | -24.0%  | 23.1% | -44.0%  | 0.4  | 458.2  |
| 2023-2025  | -55.0%  | 58.5% | -118.0% | 0.3  | 299.0  |

**Analysis:** The table presents a mixed picture.

*   **CAGR:** Compounded Annual Growth Rate shows significant volatility, with both positive and negative periods.
*   **MDD:** Maximum Drawdown also varies considerably, indicating the level of risk.
*   **Alpha:** Shows UNH's performance relative to the market. The consistently negative values (especially in recent periods) indicates underperformance of UNH relative to its benchmark index.
*   **Beta:** Shows the volatility of UNH relative to the market. The Beta decreasing indicates that UNH is becoming less sensitive to market movements.
*   **Cap(B):** Market capitalization shows a substantial increase over time, but with some recent decline, reflecting the stock's recent price weakness.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 336.40
*   **Previous Close:** 330.11
*   **Change:** 1.91
*   **5-day SMA:** 331.89
*   **20-day SMA:** 330.90
*   **60-day SMA:** 337.34

**Analysis:** The stock price has recently increased (change of 1.91). The 5-day and 20-day SMAs are below the 60-day SMA, suggesting a potential short-term uptrend following a period of weakness.

**3) Indicator Analysis**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI:** 49.62 (Neutral)
*   **PPO:** 0.1859
*   **Hybrid Signal:**  cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent (20 days) relative divergence change:** 1.9 (+): 단기상승 (Short-term rise)
*   **Expected Return (%):** -285.6 (Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.)

**Analysis:**

*   **MRI:** Indicates medium investment recommended, suggesting moderate risk.
*   **RSI:** The RSI is close to 50, suggesting a neutral condition, neither overbought nor oversold.
*   **PPO:**  The PPO (Percentage Price Oscillator) is slightly positive.
*   **Hybrid Signal:** Suggests a cautious buying strategy (90% of cash).
*   **Relative Divergence Change:** A positive change suggests a recent improvement in performance relative to the S&P 500.
*   **Expected Return:**  The extremely negative expected return is a major red flag, suggesting very poor future performance relative to the S&P 500.

**4) Recent News & Significant Events**

*   **UnitedHealth Group Stock (UNH) Opinions on Recent Price Surge and 2026 Outlook**
*   **UnitedHealth Group (UNH) Prepares for Operational Changes Following External Audit**
*   **3 Risks That Can Make UnitedHealth Stock Unattractive**
*   **UnitedHealth: Valuation Is Reset, Bull Case Is Still Standing Tall (NYSE:UNH)**
*   **UnitedHealth (UNH) stock closes up 1.9% to start 2026 as earnings loom**
*   **Olstein Capital Management L.P. Sells 8,500 Shares of UnitedHealth Group Incorporated $UNH**

**Analysis:** The news headlines paint a mixed picture.

*   There's talk of a recent price surge, operational changes after an audit, and analyst opinions supporting both bullish and bearish views (reset valuation, bull case vs. risks making the stock unattractive). The 1.9% increase at the start of 2026 is positive in the short term. A key negative is that Olstein Capital Management sold a significant number of shares, which could indicate a lack of confidence.

**4-2) Analyst Opinions:**

*   **Target Price (avg/high/low):** 392.24 / 440.00 / 280.00

**Analysis:** The average analyst target price is significantly above the current price (336.40), suggesting potential upside according to analysts. However, the range is wide (280.00 - 440.00), indicating considerable uncertainty among analysts.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출           |
|------------|------|----------------|
| 2025-10-28 | 2.59 | 113.16 B$     |
| 2025-08-11 | 3.76 | 111.62 B$     |
| 2025-05-07 | 6.9  | 109.58 B$     |
| 2024-11-04 | 6.56 | 100.82 B$     |
| 2025-10-28 | 6.56 | 100.82 B$     |

**Analysis:**

*   **Revenue:** Revenue has generally been increasing, indicating growth in the business.
*   **EPS:** EPS (Earnings Per Share) is volatile.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|----------------|
| 2025-09-30   | $113.16B   | 18.24%          |
| 2025-06-30   | $111.62B   | 17.93%          |
| 2025-03-31   | $109.58B   | 21.70%          |
| 2024-12-31   | $100.81B   | 21.14%          |
| 2024-09-30   | $100.82B   | 22.84%          |

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-09-30   | $95.79B   | 2.45%  |
| 2025-06-30   | $94.72B   | 3.60%  |
| 2025-03-31   | $95.04B   | 6.62%  |
| 2024-12-31   | $92.66B   | 5.98%  |
| 2024-09-30   | $94.53B   | 6.41%  |

**Analysis:**

*   **Revenue:** Revenue is growing consistently.
*   **Profit Margin:** Profit margins are relatively stable.
*   **Equity:** Equity has generally been increasing.
*   **ROE:** ROE (Return on Equity) has been decreasing.

**7) Comprehensive Analysis (Summary)**

UNH's recent performance has been significantly worse than the S&P 500. Recent news is mixed, with some positive price movement, but also concerns about operational changes and a large share sale by Olstein Capital Management. Analyst target prices are above the current price, but with a wide range of opinions. Revenue is growing, but EPS is volatile, and ROE is declining. The extremely negative expected return is a major concern.

**Overall Recommendation:**

Based on the provided data, a cautious approach is warranted. The underperformance relative to the S&P 500, the negative expected return, and the mixed news flow suggest that UNH is a risky investment at this time. While analysts see potential upside, the volatility in earnings and the recent share sale raise red flags. Further research is needed to understand the underlying reasons for the underperformance and to assess the long-term prospects of the company. I would not recommend a significant investment in UNH based on this information alone.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.